Lunai Bioworks Inc. (RENB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 477.03M |
| Enterprise Value | 487.11M |
| P/E Ratio | -0.06 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 742.59 |
| Price/Book Ratio | -1.12 |
| Enterprise/Revenue | 659.31 |
| Enterprise/EBITDA | -0.11 |
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -6,125.68 |
| Operating Margin | -469.92 |
| Return On Assets | -13.01 |
| Return On Equity | 8.93 |
| Revenue | 0 |
| Revenue/Share | 0.01 |
| Gross Profit | 0 |
| EBITDA | -188.84M |
| Net Income | -178.01M |
| Diluted EPS | -1.08 |
| Total Cash | 3.16M |
| Total Cash/Share | 1.01 |
| Total Debt | 1.41M |
| Total Debt/Equity | -0.15 |
| Current Ratio | 0.19 |
| Book Value Per Share | -3.06 |
| 52-Week Change | -73.7 |
| 52-Week High | 21 |
| 52-Week Low | 1.12 |
| Moving Average 50 Days | 1.96 |
| Moving Average 200 Days | 4.41 |
| Average Volume | 218,513 |
| Shares Outstanding | 23.18M |
| % Held by Institutions | 4.94 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | September 30, 2025 |